Seguir
F.J. Dekker
F.J. Dekker
Associate professor
Dirección de correo verificada de rug.nl - Página principal
Título
Citado por
Citado por
Año
A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis
G Siegel, G Obernosterer, R Fiore, M Oehmen, S Bicker, M Christensen, ...
Nature cell biology 11 (6), 705-716, 2009
5752009
Small-molecule inhibition of APT1 affects Ras localization and signaling
FJ Dekker, O Rocks, N Vartak, S Menninger, C Hedberg, R Balamurugan, ...
Nature chemical biology 6 (6), 449-456, 2010
4112010
Histone acetyl transferases as emerging drug targets
FJ Dekker, HJ Haisma
Drug discovery today 14 (19-20), 942-948, 2009
3742009
Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions
M Schmidt, FJ Dekker, H Maarsingh
Pharmacological reviews 65 (2), 670-709, 2013
3372013
Histone acetyltransferases: challenges in targeting bi-substrate enzymes
H Wapenaar, FJ Dekker
Clinical epigenetics 8, 1-11, 2016
2352016
Inflammation, cancer and oxidative lipoxygenase activity are intimately linked
R Wisastra, FJ Dekker
Cancers 6 (3), 1500-1521, 2014
2022014
Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation
M Ghizzoni, HJ Haisma, H Maarsingh, FJ Dekker
Drug discovery today 16 (11-12), 504-511, 2011
1652011
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases
FJ Dekker, T van den Bosch, NI Martin
Drug discovery today 19 (5), 654-660, 2014
1562014
Light‐controlled histone deacetylase (HDAC) inhibitors: towards photopharmacological chemotherapy
W Szymanski, ME Ourailidou, WA Velema, FJ Dekker, BL Feringa
Chemistry–A European Journal 21 (46), 16517-16524, 2015
1422015
6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site
M Ghizzoni, J Wu, T Gao, HJ Haisma, FJ Dekker, YG Zheng
European journal of medicinal chemistry 47, 337-344, 2012
1382012
Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation
NGJ Leus, MRH Zwinderman, FJ Dekker
Current opinion in chemical biology 33, 160-168, 2016
1332016
Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras‐signaling modulators palmostatin B and M
M Rusch, TJ Zimmermann, M Bürger, FJ Dekker, K Görmer, G Triola, ...
Angewandte Chemie-International Edition 50 (42), 9838, 2011
1322011
The genetics of asthma and the promise of genomics-guided drug target discovery
ZW El-Husseini, R Gosens, F Dekker, GH Koppelman
The Lancet Respiratory Medicine 8 (10), 1045-1056, 2020
1232020
HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 …
NGJ Leus, PE van der Wouden, T van den Bosch, WTR Hooghiemstra, ...
Biochemical pharmacology 108, 58-74, 2016
1172016
Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative
M Ghizzoni, A Boltjes, C de Graaf, HJ Haisma, FJ Dekker
Bioorganic & medicinal chemistry 18 (16), 5826-5834, 2010
1012010
Engineering methylaspartate ammonia lyase for the asymmetric synthesis of unnatural amino acids
H Raj, W Szymański, J De Villiers, HJ Rozeboom, VP Veetil, CR Reis, ...
Nature Chemistry 4 (6), 478-484, 2012
962012
Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC)
R Balamurugan, FJ Dekker, H Waldmann
Molecular BioSystems 1 (1), 36-45, 2005
912005
Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics
FJ Dekker, MA Koch, H Waldmann
Current opinion in chemical biology 9 (3), 232-239, 2005
862005
Development of highly potent inhibitors of the Ras‐targeting human acyl protein thioesterases based on substrate similarity design
C Hedberg, FJ Dekker, M Rusch, S Renner, S Wetzel, N Vartak, ...
Angewandte Chemie 123 (42), 10006-10011, 2011
802011
Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras
J Xu, C Hedberg, FJ Dekker, Q Li, KM Haigis, E Hwang, H Waldmann, ...
Blood, The Journal of the American Society of Hematology 119 (4), 1032-1035, 2012
782012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20